Consumer reports on medicines – CRM: Policy and Practice

Subtitle: Consensus Document adopted at the First International Conference on CRM September 29–October 1, 2000, Sigtuna, Sweden

Article type: Research Article

Abstract: An international meeting with wide multidisciplinary participation was convened to define the case for direct reporting by consumers of suspected, supposed or proven adverse reactions to medicines; the meeting was structured to provide participants with the tools and the inspiration needed to establish systems that capitalise on user experiences. Participants included experts from the medical and pharmaceutical professions, drug regulatory authorities, the consumer movement and the World Health Organization. The participants examined experience with such schemes in various countries to date, and the role of such approaches in complementing existing professional‐based systems for the reporting of supposed adverse drug reactions.

Journal: International Journal of Risk and Safety in Medicine, vol. 13, no. 2-3, pp. 117-127, 2000